Azimi, A., Caramuta, S., Seashore‐Ludlow, B., Boström, J., Robinson, J. L., Edfors, F., . . . Maddalo, G. (2018). Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors. Mol Syst Biol.
استشهاد بنمط شيكاغوAzimi, Alireza, et al. "Targeting CDK2 Overcomes Melanoma Resistance against BRAF and Hsp90 Inhibitors." Mol Syst Biol 2018.
MLA استشهادAzimi, Alireza, et al. "Targeting CDK2 Overcomes Melanoma Resistance against BRAF and Hsp90 Inhibitors." Mol Syst Biol 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.